Stockholders' Equity Attributable to Parent of THC Therapeutics, Inc. from 31 Jul 2010 to 31 Jul 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
THC Therapeutics, Inc. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Jul 2010 to 31 Jul 2024.
  • THC Therapeutics, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Jul 2024 was $3,801,555, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

THC Therapeutics, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $3,801,555 -$491,722 -15% 31 Jul 2024 10-K 27 Feb 2026 2024 FY
Q1 2024 $3,519,831 -$242,939 -7.4% 30 Apr 2024 10-Q 13 Nov 2024 2024 Q3
Q4 2023 $3,895,373 -$524,126 -16% 31 Jan 2024 10-Q 13 Nov 2024 2024 Q3
Q3 2023 $3,372,318 +$1,850,671 +35% 31 Oct 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $3,309,833 -$199,866 -6.4% 31 Jul 2023 10-K 27 Feb 2026 2024 FY
Q1 2023 $3,276,892 +$582,061 +15% 30 Apr 2023 10-Q 13 Nov 2024 2024 Q3
Q4 2022 $3,371,247 -$137,572 -4.3% 31 Jan 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2022 $5,222,989 -$2,294,655 -78% 31 Oct 2022 10-Q 13 Nov 2024 2024 Q3
Q2 2022 $3,109,967 -$632,641 -26% 31 Jul 2022 10-K 27 Feb 2026 2024 FY
Q1 2022 $3,858,953 -$1,999,532 -108% 30 Apr 2022 10-Q 09 Jan 2024 2023 Q3
Q4 2021 $3,233,675 -$1,516,034 -88% 31 Jan 2022 10-Q 09 Jan 2024 2023 Q3
Q3 2021 $2,928,334 -$1,081,633 -59% 31 Oct 2021 10-Q 09 Jan 2024 2023 Q3
Q2 2021 $2,477,326 -$733,752 -42% 31 Jul 2021 10-K 26 Feb 2024 2023 FY
Q1 2021 $1,859,421 +$315,125 +14% 30 Apr 2021 10-Q 16 Jun 2022 2022 Q3
Q4 2020 $1,717,641 -$118,455 -7.4% 31 Jan 2021 10-Q 16 Jun 2022 2022 Q3
Q3 2020 $1,846,701 -$964,113 -109% 31 Oct 2020 10-Q 16 Jun 2022 2022 Q3
Q2 2020 $1,743,574 +$35,077 +2% 31 Jul 2020 10-K 25 Nov 2022 2022 FY
Q1 2020 $2,174,546 -$1,236,921 -132% 30 Apr 2020 10-Q 22 Jun 2021 2021 Q3
Q4 2019 $1,599,186 -$119,538 -8.1% 31 Jan 2020 10-Q 22 Jun 2021 2021 Q3
Q3 2019 $882,588 -$2,732,229 -148% 31 Oct 2019 10-Q 22 Jun 2021 2021 Q3
Q2 2019 $1,778,651 -$3,716,741 -192% 31 Jul 2019 10-Q 16 Jun 2022 2022 Q3
Q1 2019 $937,625 30 Apr 2019 10-Q 22 Jun 2020 2020 Q3
Q4 2018 $1,479,648 31 Jan 2019 10-Q 22 Jun 2020 2020 Q3
Q3 2018 $1,849,641 31 Oct 2018 10-Q 22 Jun 2020 2020 Q3
Q2 2018 $1,938,090 +$2,133,959 31 Jul 2018 10-K 04 Nov 2020 2020 FY
Q2 2017 $195,869 31 Jul 2017 10-K/A 18 Nov 2019 2020 FY
Q1 2014 $123,939 -$238,655 -208% 30 Apr 2014 10-Q 12 Jun 2014 2013 Q3
Q4 2013 $104,039 -$239,057 -177% 31 Jan 2014 10-Q 12 Jun 2014 2013 Q2
Q3 2013 $60,316 -$246,216 -132% 31 Oct 2013 10-Q 11 Jun 2014 2013 Q1
Q2 2013 $47,053 -$158,959 -77% 31 Jul 2013 10-Q 12 Jun 2014 2013 Q3
Q1 2013 $114,716 +$67,663 +144% 30 Apr 2013 10-Q 11 Jun 2013 2013 Q3
Q4 2012 $135,018 +$204,054 31 Jan 2013 10-Q 21 Mar 2013 2013 Q2
Q3 2012 $185,900 +$252,536 31 Oct 2012 10-Q 14 Dec 2012 2013 Q1
Q2 2012 $206,012 +$270,948 31 Jul 2012 10-K 09 Jun 2014 2013 FY
Q1 2012 $47,053 14 Mar 2012 10-Q 11 Jun 2014 2013 Q1
Q4 2011 $69,036 31 Jan 2012 10-Q 21 Mar 2012 2012 Q2
Q3 2011 $66,636 31 Oct 2011 10-Q 20 Dec 2011 2012 Q1
Q2 2011 $64,936 -$24,772 -62% 31 Jul 2011 10-K 09 Jun 2014 2013 FY
Q2 2010 $40,164 31 Jul 2010 10-K 09 Jun 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.